DiaMedica Therapeutics Inc.

Ownership Transactions Reported by 21 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	3	+5.8M	100%	$3.92	+$22.8M
Sells	0
Net	+3	+5.8M	100%		+$22.8M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jan Stahlberg	10%+ Owner	$46.6M	+$11.4M	+32.2%	Aug 13, 2025
Thomas Von Koch	10%+ Owner	$29.3M	+$10M	+51.7%	Jul 23, 2025
Richard Jacinto II	10%+ Owner	$17.4M	+$1.4M	+8.77%	Jul 23, 2025
David J. Wambeke	Chief Business Officer	$3.42M			Jun 1, 2025
Randall Michael Giuffre	Director	$2.77M			Jun 1, 2025
Richard D. Pilnik	Director	$1.44M			Apr 7, 2025
James T. Parsons	Director	$448K			Jun 1, 2025
Dietrich John Pauls	President & CEO, Director	$445K			Jun 1, 2025
Charles Pauling Semba	Director	$275K			Jun 1, 2025
Scott Kellen	CFO & Secretary	$210K			Jun 1, 2025
Amy L. Burroughs	Director	$205K			Jan 3, 2023
Richard Kuntz	Director	$129K			Jun 1, 2025
Harry W. Alcorn Jr	SVP, Clinical Operations	$123K			Sep 15, 2021
Dominic R. Cundari	Chief Commercial Officer	$7.84K			Jun 1, 2024
Tanya Lewis	Director	$0			Jun 1, 2025
Daniel J. O'Connor	Director	$0			Feb 20, 2025
Masuoka K. Lorianne	Chief Medical Officer				Jan 22, 2024
Julie VanOrsdel Daves	SVP Clinical Development Oper.				Jun 1, 2023
Sydney A. Gilman	VP, Regulatory Affairs				Jul 28, 2021
Kirsten L. Gruis	Chief Medical Officer				Jun 1, 2023
Julie Krop	Chief Marketing Officer				Aug 11, 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.